MTS Health Investors Announces the Sale of DNA Diagnostics…
NEW YORK, October 13, 2015 — MTS Health Investors, LLC (“MTS”), the New York-based healthcare private equity firm, announced today that it has successfully completed the sale of its portfolio company, DNA Diagnostics Center (“DDC” or the “Company”), to GHO Capital for $110 million. DDC is a market leading diagnostics business and is one of … Read More